Global Health Ltd Q2 FY27 profit rises 38% to Rs 219 crore

Global Health Ltd reported Q2 FY27 consolidated net profit of Rs 219.14 crore, up 38.35% year on year, as revenue from operations rose 33.64% to Rs 1,469.04 crore and operating EBITDA increased 60.25% to Rs 370.09 crore. The September-quarter performance reflected bed additions and higher patient volumes across its hospital network.

What did Global Health Ltd report for Q2 FY27?

Global Health Ltd reported consolidated revenue from operations of Rs 1,469.04 crore for Q2 FY27, compared with Rs 1,099.22 crore in Q2 FY26. The 33.64% year-on-year increase was accompanied by operating EBITDA of Rs 370.09 crore, against Rs 230.94 crore a year earlier.

Net profit stood at Rs 219.14 crore, compared with Rs 158.40 crore in the corresponding quarter of the previous financial year. This represented a 38.35% year-on-year rise. The company released its financial results for the July-September quarter on November 3, 2026.

What drove Global Health Ltd's revenue and profit growth?

Global Health Ltd attributed the quarterly growth to bed additions and volume growth. Revenue expansion was stronger than the growth recorded by its established cluster, while operating EBITDA rose faster than revenue, lifting the reported operating EBITDA margin to 25.2% from 21.0% in Q2 FY26.

The company operates under the Medanta brand. Its financial update showed that growth was spread across its hospital clusters, with Cluster 2, comprising Lucknow, Patna and Noida, recording a faster pace of expansion than Cluster 1, which includes Gurugram, Indore and Ranchi.

How did Global Health Ltd's hospital clusters perform?

Global Health Ltd's Cluster 1 generated revenue of Rs 822.9 crore, up 18% year on year, and operating EBITDA of Rs 181 crore, up 29%. Inpatient volumes increased 15%, while occupancy improved to 66% from 61% a year earlier.

Cluster 2 reported revenue of Rs 579 crore, up 63% from Rs 354.7 crore in Q2 FY26. Its operating EBITDA increased 110% to Rs 183.7 crore. Inpatient volumes rose 52%, occupied bed days increased 43%, average revenue per patient rose 8%, and occupancy improved to 67% from 62%.

What was the contribution from the Noida hospital?

Global Health Ltd said its Noida hospital achieved EBITDA breakeven during Q2 FY27. The facility reported revenue from operations of Rs 105.9 crore and operating EBITDA of Rs 8.6 crore during the quarter.

The Noida hospital had operational capacity of 482 beds, according to the earnings-call highlights. Its move to EBITDA breakeven is relevant because new hospital capacity can weigh on margins during the initial ramp-up period. The reported positive EBITDA contribution coincided with the stronger growth in Cluster 2.

Why do occupancy and margins matter for Global Health Ltd?

Global Health Ltd's reported occupancy gains indicate higher utilisation of its hospital infrastructure. Cluster 1 occupancy rose by five percentage points year on year, while Cluster 2 occupancy rose by the same amount. Higher inpatient volumes were reported in both clusters.

The company's operating EBITDA margin increased by 4.2 percentage points to 25.2%. Operating EBITDA growth of 60.25% exceeded revenue growth of 33.64%, showing that profitability improved in the reported quarter. The disclosed figures do not provide a forward financial forecast, but they establish the base against which subsequent quarterly performance will be assessed.

How was the Q2 FY27 result communicated to investors?

Global Health Ltd announced its Q2 FY27 results on November 3, 2026. It held an earnings conference call on November 4, 2026 at 2:00 PM IST, hosted by Investec Capital Services, to cover the second-quarter and half-year financial results.

The company subsequently announced that an audio recording of the call was available through its investor relations website. The reported information covers the July-September 2026 period and includes consolidated financial results as well as operational indicators for the company’s hospital clusters.

Conclusion

Global Health Ltd's Q2 FY27 results showed consolidated revenue of Rs 1,469.04 crore, operating EBITDA of Rs 370.09 crore and net profit of Rs 219.14 crore. Revenue, volumes, occupancy and operating profitability increased year on year, while the Noida hospital reached EBITDA breakeven.

Investors will watch the company’s next reported quarterly results for the sustainability of Cluster 2 growth, occupancy trends across the network and the continued financial contribution from the Noida hospital. The company has disclosed the November 4 earnings-call recording through its investor relations website.